Advertisement

Abstract

• Many factors can lead to pathologically increased hair loss. The pathologic dynamics of hair loss can be related to disorders of hair cycling.

• Telogen effluvium is hair loss that results from increased shedding of hairs from the telogen phase of the hair cycle. On the basis of changes in different phases of the follicular cycle, telogen effluvium is classified into varied functional types.

• Telogen effluvium presents either as an acute and diffuse hair loss brought about by a variety of triggers, or as chronic telogen effluvium, which is defined as diffuse telogen hair loss that persists >6 months with unexplored or unknown etiologies.

• Management of diffuse hair loss depends on the cause and underlying pathomechanism in its relation to the hair growth cycle. Once the diagnosis is established, treatment appropriate for that diagnosis is likely to control the hair loss. Chronic telogen effluvium of unknown origin can be satisfactorily handled with unpatronizing sympathy and by firm exposition of the dynamics of hair growth.

Keywords

Hair Follicle Hair Loss Hair Growth Alopecia Areata Hair Cycle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahrens J (1994) Systemische Behandlung des diffusen Haarausfalls. Therapiewoche Schweiz 10:551–554Google Scholar
  2. 2.
    Arck PC, Handjiski B, Hagen E et al (2001) Indications for a ‘brain-hair follicle axis (BHA)’: inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 15:2536–2538PubMedGoogle Scholar
  3. 3.
    Aydingöz IE, Ferhanoglu B, Güney O (1999) Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol 13:65–67PubMedCrossRefGoogle Scholar
  4. 4.
    Baden HP, Kvedar JC, Magro CM (1992) Loose anagen hair as a cause of hereditary hair loss in children. Arch Dermatol 128:1349–1353PubMedCrossRefGoogle Scholar
  5. 5.
    Baker B, Wilson C, Davis A et al (1991) Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead o failure of hair regrowth. Bone Marrow Transpl 7:43–47Google Scholar
  6. 6.
    Barraud-Klenovsek MM, Trüeb RM (2000) Congenital hypotrichosis due to short anagen. Br J Dermatol 143:612–617PubMedCrossRefGoogle Scholar
  7. 7.
    Borelli S, Trüeb RM (1999) Androgenetic alopecia with prepubertal onset? Dermatology 199:96Google Scholar
  8. 8.
    Bratel J, Haraldson T, Meding B et al (1997) Potential side effects of dental amalgam restorations. An oral and medical investigation. Eur J Oral Sci 105:234–243PubMedCrossRefGoogle Scholar
  9. 9.
    Braun-Falco O (1966) Dynamik des normalen und pathologischen Haarwachstums. Arch Klein Exp Dermatol 227:418–452Google Scholar
  10. 10.
    Braun-Falco O, Zaun H (1963) Über die Beteiligung des gesamten Capillitiums bei Alopecia areata. Hautarzt 13:342Google Scholar
  11. 11.
    Brodin M (1987) Drug-related alopecia. Dermatol Clin 5:571–579PubMedGoogle Scholar
  12. 12.
    Budde J, Tronnier H, Rahlfs VW et al (1993) Systemische Therapie von diffusem Effluvium und Haarstrukturschäden. Hautarzt 44:380–384PubMedGoogle Scholar
  13. 13.
    Buhl AE, Waldon DJ, Kawabe TT et al (1989) Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 92:315–20PubMedCrossRefGoogle Scholar
  14. 14.
    Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26:926–931PubMedGoogle Scholar
  15. 15.
    Cash TF, Price VH, Savin RC (1993) Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 25:569–575Google Scholar
  16. 16.
    Chartier MB, Hoss DMM, Grant-Kels JM (2002) Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol 47:809–818PubMedCrossRefGoogle Scholar
  17. 17.
    Comaisch S (1985) The thyroid and hair growth. Semin Dermatol 4:4–8Google Scholar
  18. 18.
    Cotterill JA (1996) Body dysmorphic disorder. Dermatol Clin 14:457–463PubMedCrossRefGoogle Scholar
  19. 19.
    Courtois M, Loussouarn G, Horseau S et al (1996) Periodicity in the growth and shedding of hair. Br J Dermatol 134:47–54PubMedCrossRefGoogle Scholar
  20. 20.
    Dupré A, Lassère J, Christol B et al (1977) Traitement des alopécies diffuses chroniques par le panthénol et la D-biotine injectables. Rev Med Toulouse 13 :675–677Google Scholar
  21. 21.
    Ebling FJ, Rook A. Hair. In: Rook A, Wilkinson DS, Ebling EJB (eds.) (1968) Textbook of Dermatology, Vol 2. Blackwell Scientific Publications, Oxford, pp.1355–1425Google Scholar
  22. 22.
    Elston DM, McCollough ML, Angeloni VL (1995) Vertical and transverse sections of alopecia biopsy specimens. Combining the two to maximize diagnostic yield. J Am Acad Dermatol 32:454–457PubMedCrossRefGoogle Scholar
  23. 23.
    Floersheim GL (1992) Prüfung der Wirkung von Biotin auf Haarausfall und Haarqualität. Z Hautkrankheiten 67Google Scholar
  24. 24.
    Frenkel MJ, Gillepsie JM, Reis PJ (1974) Factors influencing the biosynthesis of the tyrosine-rich proteins of wool. Aust J Biol Sci 27:31–38PubMedGoogle Scholar
  25. 25.
    Gillespie JM, Reis PJ (1966) Dietary regulated biosynthesis of high-sulfur wool proteins. Biochem. J 98:669–677PubMedGoogle Scholar
  26. 26.
    Guarrera M, Semino MT, Rebora A (1997) Quantitating hair loss in women: a critical approach. Dermatology 1997:12–16Google Scholar
  27. 27.
    Gummer CL (1985) Diet and hair loss. Semin Dermatol 4:35–39Google Scholar
  28. 28.
    Guy WB, Edmundson WF (1960) Diffuse cyclic hair loss in women. Arch Dermatol 81:205–227PubMedGoogle Scholar
  29. 29.
    Hamilton JB (1951) Patterned loss of hair in man: types and incidence. Ann NY Acad Sci 53:708–728PubMedCrossRefGoogle Scholar
  30. 30.
    Hamm H, Traupe H (1989) Loose anagen hair of childhood: the phenomenon of easily pluckable hair. J Am Acad Dermatol 20:242–248PubMedGoogle Scholar
  31. 31.
    Headington JT (1991) The histopathology of alopecia areata (abstract) J Invest Dermatol 96 (Suppl):69SCrossRefGoogle Scholar
  32. 32.
    Headington JT (1993) Telogen effluvium. New concepts and review. Arch Dermatol 129:356–363PubMedCrossRefGoogle Scholar
  33. 33.
    Hoffmann R (2001) TrichoScan: combining epiluminiscence microscopy with digital image analysis for the measurement of hair growth in vivo. Eur J Dermatol 11:362–368PubMedGoogle Scholar
  34. 34.
    Huda W, Peters KR (1994) Radiation-induced temporary epilation after a neuroradiologically guided embolization procedure. Radiology 193:642–644PubMedGoogle Scholar
  35. 35.
    Ihm CW, Lee JY (1991) Evaluation in daily hair counts. Dermatologica 182:67PubMedGoogle Scholar
  36. 36.
    Kasteler JS, Callen JP (1994) Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed. JAMA 272:1939–1941PubMedCrossRefGoogle Scholar
  37. 37.
    Kligman AM (1961) Pathologic dynamics of human hair loss, I: telogen effluvium. Arch Dermatol 83:175–198PubMedGoogle Scholar
  38. 38.
    Kossard S (1999) Diffuse alopecia with stem cell folliculitis. Chronic diffuse alopecia areata or a distinct entity? Am J Dermatopathol 21:46–50PubMedCrossRefGoogle Scholar
  39. 39.
    Kullavanijaya P, Gritiyarangsan P, Bisalbutra P et al (1992) Absence of effects of dimethicone- and non-dimethicone-containing shampoos on daily hair loss rates. J Soc Cosmet Chem 43:195–206Google Scholar
  40. 40.
    Lengg N, Heidecker B, Seifert B et al (2007) Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind placebo-controlled trial. Therapy 4:59–65CrossRefGoogle Scholar
  41. 41.
    Lindberg NE, Lindberg E, Larsson G (1994) Psychologic factors in the eiology of amalgam illness. Acta Odontol Scand 52:219–228PubMedCrossRefGoogle Scholar
  42. 42.
    Llau ME, Virabin R. Montastruc JL (1995) Les aopecies medicamenteuses: revue de la literature. Therapie 50:145–150PubMedGoogle Scholar
  43. 43.
    Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247–254PubMedCrossRefGoogle Scholar
  44. 44.
    McDonagh AJG, MacDonald-Hull SP, Messenger AG et al (2003) Clinical subtypes and disease associations with alopecia areata (abstract P-21). In: European Hair Research Society 10th Meeting 2003. Proceedings: p. 39Google Scholar
  45. 45.
    Mirmirani P, Hessol N, Maurer T et al (2001) Prevalence of hair disorders in the women’s interagency HIV study (abstract 265). J Invest Dermatol 117:434Google Scholar
  46. 46.
    Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68:1359–1365PubMedGoogle Scholar
  47. 47.
    Norwood O, Lehr B (2000) Female androgenetic alopecia: a separate entity. Dermatol Surg 26:679–682PubMedCrossRefGoogle Scholar
  48. 48.
    Olsen EA. Clinical tools for assessing hair loss. In: Olsen EA (ed.) (1993) Disorders of Hair Growth: Diagnosis and Treatment. New York, McGraw-Hill, pp 59–69Google Scholar
  49. 49.
    Olsen EA (2001) Female pattern hair loss. J Am Acad Dermatol 45 (Suppl):S69–S119CrossRefGoogle Scholar
  50. 50.
    Olsen EA, Hordinsky M, Roberts JL et al (2002) Female pattern hair loss. J Am Acad Dermatol 47:795PubMedCrossRefGoogle Scholar
  51. 51.
    Orme S, Cullen DR, Messenger AG (1999) Diffuse female hair loss: are androgens necessary? Br J Dermatol 141:521–523PubMedCrossRefGoogle Scholar
  52. 52.
    Panizzon RG, Goldtschmitdt H. Radiation reactions and sequelae. In: Goldschmidt H, Panizzon (eds.) (1991) Modern Radiation Therapy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  53. 53.
    Paus R (1996) Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 3:248–258Google Scholar
  54. 54.
    Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341:491–497PubMedCrossRefGoogle Scholar
  55. 55.
    Petri H, Perchalla P, Tronnier H (1990) Die Wirksamkeit einer medikamentösen Therapie bei Haarstrukturschäden und diffusen Effluvien – vergleichende Doppelblindstudie. Schweiz Rundsch Med Prax 79:1457–1462 PubMedGoogle Scholar
  56. 56.
    Pierard GE (1979) Toxic effects of metals from the environment on hair growth and structure. J Cutan Pathol 6:237–242PubMedCrossRefGoogle Scholar
  57. 57.
    Pierard-Franchimont C, Pierard GE (2001) Teloptosis, a turning point in hair shedding biorhythms. Dermatology 203:115–117PubMedCrossRefGoogle Scholar
  58. 58.
    Price VH, Gummer CL (1989) Loose anagen syndrome. J Am Acad Dermatol 20:249–256PubMedGoogle Scholar
  59. 59.
    Rampini P, Guarrera M, Rampini E, et al (1999) Assessing hair shedding in children. Dermatology 199:256–257PubMedCrossRefGoogle Scholar
  60. 60.
    Rebora A (1997) Telogen effluvium. Dermatology 195:209–212PubMedCrossRefGoogle Scholar
  61. 61.
    Reeves JRT, Maibach HI, Drug and chemical induced hair loss. In: Marzulli FN, Maibach HI (eds.) (1977) Advances in Modern Toxicology, Vol 4. Hemisphere Publishing, Washington, pp. 487–500Google Scholar
  62. 62.
    Reis PJ, Tunks DA, Sharry LF (1973) Plasma amino acid patterns in sheep receiving abomasal infusions of methionine and cystine. Aust J Biol Sci 26:635–644PubMedGoogle Scholar
  63. 63.
    Roudier-Pujol C, Jan V (2000) Alopecies medicamenteuses. Ann Dermatol Venereol Suppl 127:26–28Google Scholar
  64. 64.
    Rushton DH (1993) Management of hair loss in women. Dermatol Clin 11:47–53PubMedCrossRefGoogle Scholar
  65. 65.
    Rushton DH, Ramsay ID, James KC (1990) Biochemical and trichological characterization of diffuse alopeca in women. Br J Dermatol 123:187–197PubMedCrossRefGoogle Scholar
  66. 66.
    Sabouraud R (1932) Diagnostic et Traitement des Affections du Cuir Chevelu. Paris, MassonGoogle Scholar
  67. 67.
    Sadick NS (1993) Clinical and laboratory evaluation of AIDS trichopathy. Int J Dermatol 32:33–38PubMedCrossRefGoogle Scholar
  68. 68.
    Sinclair R (1999) Diffuse hair loss. Int J Dermatol 38 (Suppl. 1):8–18PubMedCrossRefGoogle Scholar
  69. 69.
    Sinclair R (2002) There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 147:982–984PubMedCrossRefGoogle Scholar
  70. 70.
    Spencer LV, Callen JP (1987) Hair loss in systemic disease. Dermatol Clin 5:565–570PubMedGoogle Scholar
  71. 71.
    Stroud JP (1987) Diagnosis and management of the hair loss patient. Cutis 40:272–276PubMedGoogle Scholar
  72. 72.
    Sulzberger MB, Witten VH, Kopf AW (1960) Diffuse alopecia in women. Arch Dermatol 81:556PubMedGoogle Scholar
  73. 73.
    Tosti A, Misciali C, Piraccini BM et al (1994) Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 10:310–317CrossRefGoogle Scholar
  74. 74.
    Tosti A, Peluso AM, Misciali C et al (1997) Loose anagen hair. Arch Dermatol 133:1089–1093PubMedCrossRefGoogle Scholar
  75. 75.
    Tosti A, Piraccini BM, van Neste DJ (2001) Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol 137:187–190PubMedGoogle Scholar
  76. 76.
    Tran D, Sinclair RD, Schwarer AP et al (2000) Permanent alopecia following chemotherapy and bone marrow transplantation. Austral J Dermatol 41:106–108CrossRefGoogle Scholar
  77. 77.
    Trüeb RM (2000) Idiopathic chronic telogen effluvium in women. Hautarzt 51:899–905PubMedCrossRefGoogle Scholar
  78. 78.
    Trüeb RM, Swiss Trichology Study Group (2000) Interaction between the medical profession, hairdressers and the media in the management of hair loss. Hautarzt 51:729–732PubMedCrossRefGoogle Scholar
  79. 79.
    Vowels M, Chan LL, Giri N et al (1993) Factors affecting hair regrowth after bone marrow transplanttion. Bone Marrow Transpl 347–350Google Scholar
  80. 80.
    Whiting D (1993) Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 28:755–763PubMedCrossRefGoogle Scholar
  81. 81.
    Whiting DA (1996) Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35:899–906PubMedCrossRefGoogle Scholar
  82. 82.
    Wysenbeek AI, Leibovici L, Amit M, et al (1991) Alopecia in systemic lupus erythematosus. Relation to disease manifestations. J Rheumatol 18:1185–1186PubMedGoogle Scholar
  83. 83.
    York J, Nicholson T, Minors P, et al (1998) Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 82:1044–1046PubMedGoogle Scholar
  84. 84.
    Zviak C, Dawber R. Hair structure, function and physicochemical properties. In: Zvaik C (ed.) (1986) The Science of Hair Care. Marcel Dekker, New York, pp. 1–48Google Scholar

Copyright information

© Springer London 2008

Authors and Affiliations

  • Ralph M. Trüeb
    • 1
  1. 1.Department of DermatologyUniversity Hospital of ZürichZürichSwitzerland

Personalised recommendations